Log in or Sign up for Free to view tailored content for your specialty!
Juvenile Arthritis News
Pfizer COVID-19 vaccine offers similar protection in adolescents with, without IRDs
The Pfizer-BioNTech COVID-19 vaccine offers similar protection against the disease in adolescent patients with and without inflammatory or immune rheumatic conditions, according to data published in Rheumatology.
Quality of life in children with juvenile arthritis linked to caregivers’ quality of life
Higher health-related quality of life scores in children with juvenile idiopathic arthritis correspond to higher career- and health-related quality of life scores for their caregivers, according to data published in Pediatric Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Humira biosimilar approval paused after FDA finds ‘deficiencies’ at manufacturing facility
The FDA approval of Alvotech’s Humira biosimilar is on hold until the company can address “certain deficiencies” the administration found during an inspection of a manufacturing facility, according to a press release.
Emotional distress may trigger PFAPA flares
Emotional distress may trigger flares of periodic fever, aphthous stomatitis, pharyngitis and adenitis, or PFAPA syndrome, according to data published in Pediatric Rheumatology.
FDA approves citrate-free, high concentration formulation of Humira biosimilar
The FDA has approved a citrate-free, 100 mg/mL formulation of the Humira biosimilar Hadlima, according to a statement released by Samsung Bioepis and Organon.
Half of children with JIA enter adult care with worse disease activity, need better plan
ORLANDO — As many as one-half of children with juvenile idiopathic arthritis enter adult care with increased disease activity, according to a speaker at the 2022 Rheumatology Nurses Society Conference.
Denial of methotrexate prescriptions post-Roe yields ‘condemnation’
The June 24 Supreme Court decision to overturn Roe vs. Wade continues to reverberate across all of health care, including rheumatology, dermatology and cancer treatment — and in this instance all three at once.
EULAR recommends passive immunization for tetanus in children on B-cell depleting drugs
When a tetanus toxoid vaccination is indicated, pediatric patients treated with B-cell depleting therapy in the past 6 months should receive passive immunization, according to updated EULAR vaccine recommendations.
Belimumab becomes first FDA-approved drug for pediatric lupus nephritis
The FDA has approved GlaxoSmithKline’s belimumab for the treatment of children with active lupus nephritis who are also receiving standard therapy, according to a company press release.
Infants, older patients with Kawasaki disease demonstrate different complication risks
The risks for unresponsiveness to intravenous immunoglobulin and the development of coronary artery abnormalities differ between infants and older patients with Kawasaki disease, according to data published in JAMA Network Open.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read